131 related articles for article (PubMed ID: 36638694)
21. Ask Your Provider About Cannabis: Increasing Nurse Practitioner Knowledge and Confidence.
Klein TA; Bindler R
Cannabis Cannabinoid Res; 2022 Oct; 7(5):700-705. PubMed ID: 34432530
[No Abstract] [Full Text] [Related]
22. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019.
Callaghan RC; Sanches M; Vander Heiden J; Kish SJ
Drug Alcohol Rev; 2023 Jul; 42(5):1104-1113. PubMed ID: 36908258
[TBL] [Abstract][Full Text] [Related]
23. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
[TBL] [Abstract][Full Text] [Related]
24. [Cannabis cessation interventions offered to young French users: predictors of follow-up].
Abdoul H; Le Faou AL; Bouchez J; Touzeau D; Lagrue G
Encephale; 2012 Apr; 38(2):141-8. PubMed ID: 22516272
[TBL] [Abstract][Full Text] [Related]
25. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study.
Campbell CI; Bahorik AL; Kline-Simon AH; Satre DD
Drug Alcohol Depend; 2017 Sep; 178():170-175. PubMed ID: 28651153
[TBL] [Abstract][Full Text] [Related]
26. Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls.
Hjorthøj C; La Cour P; Nordentoft M; Posselt CM
Eur J Pain; 2022 Feb; 26(2):480-491. PubMed ID: 34624164
[TBL] [Abstract][Full Text] [Related]
27. Minimizing double standards in assessing the adverse and beneficial effects of cannabis.
Hall W; Hoch E
Addiction; 2023 Sep; 118(9):1606-1608. PubMed ID: 37331720
[No Abstract] [Full Text] [Related]
28. Youth cannabis use and subsequent health service use for mood and anxiety disorders: A population-based cohort study.
McDonald AJ; Kurdyak P; Rehm J; Roerecke M; Bondy SJ
Psychiatry Res; 2024 Feb; 332():115694. PubMed ID: 38176165
[TBL] [Abstract][Full Text] [Related]
29. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
30. [Search association between cannabis abuse and bipolar disorder: A study on a sample of patients hospitalized for bipolar disorder].
Kazour F; Awaida C; Souaiby L; Richa S
Encephale; 2018 Feb; 44(1):14-21. PubMed ID: 27745717
[TBL] [Abstract][Full Text] [Related]
31. Geographical variation in hospitalization for psychosis associated with cannabis use and cannabis legalization in the United States: Submit to: Psychiatry Research.
Moran LV; Tsang ES; Ongur D; Hsu J; Choi MY
Psychiatry Res; 2022 Feb; 308():114387. PubMed ID: 35016118
[TBL] [Abstract][Full Text] [Related]
32. Exploring the association between cannabis use and depression.
Degenhardt L; Hall W; Lynskey M
Addiction; 2003 Nov; 98(11):1493-504. PubMed ID: 14616175
[TBL] [Abstract][Full Text] [Related]
33. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
[TBL] [Abstract][Full Text] [Related]
34. Cannabis use and mental health-related quality of life among individuals with depressive disorders.
Aspis I; Feingold D; Weiser M; Rehm J; Shoval G; Lev-Ran S
Psychiatry Res; 2015 Dec; 230(2):341-9. PubMed ID: 26388103
[TBL] [Abstract][Full Text] [Related]
35. [Relations between anxious, depressive and borderline symptomatology and frequency of cannabis use and dependence].
Chabrol H; Duconge E; Roura C; Casas C
Encephale; 2004; 30(2):141-6. PubMed ID: 15107716
[TBL] [Abstract][Full Text] [Related]
36. Cannabis Abuse Is Increasing and Associated with Increased Emergency Department Utilization in Gastroenterology Patients.
Gubatan J; Staller K; Barshop K; Kuo B
Dig Dis Sci; 2016 Jul; 61(7):1844-52. PubMed ID: 26935430
[TBL] [Abstract][Full Text] [Related]
37. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
[No Abstract] [Full Text] [Related]
38. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
[TBL] [Abstract][Full Text] [Related]
39. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
[TBL] [Abstract][Full Text] [Related]
40. Association of medical cannabis licensure with prescription opioid receipt: A population-based, individual-level retrospective cohort study.
Goedel WC; Macmadu A; Shihipar A; Moyo P; Cerdá M; Marshall BDL
Int J Drug Policy; 2022 Feb; 100():103502. PubMed ID: 34695720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
